Track Reata Pharmaceuticals, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Reata Pharmaceuticals, Inc. RETA · Stock Open Reata Pharmaceuticals, Inc. in new tab

172.36 USD
Add to portfolio
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Reata Pharmaceuticals, Inc. (RETA)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Reata Pharmaceuticals, Inc. Logo Reata Pharmaceuticals, Inc. Analysis (RETA)

United States Health Care Official Website Stock

Is Reata Pharmaceuticals, Inc. a good investment? Reata Pharmaceuticals, Inc. (RETA) is currently trading at 172.36 USD.

Investor FAQ

Does Reata Pharmaceuticals, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Reata Pharmaceuticals, Inc.?

Reata Pharmaceuticals, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

No detailed summary available for Reata Pharmaceuticals, Inc..

Exchange Ticker
FRA (Germany) 2R3.F
NMS (United States) RETA
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion